Aadel Chaudhuri, MD, PhD

Aadel Chaudhuri, MD, PhD, is a physician-scientist and Assistant Professor of Radiation Oncology, Genetics, Biomedical Engineering, and Computer Science at the Washington University in St. Louis. He is also leader of the Liquid Biopsy Working Group at the Washington University Siteman Cancer Center. He additionally serves as Co-Chair of the Liquid Biopsy Interest Group within the National Institutes of Health.

Dr. Chaudhuri completed his MD at Stanford, PhD at Caltech, and BS degrees in Biology and Computer Science at MIT where he was also a Goldwater Scholar. He completed his PhD in Biology under the mentorship of Nobel Laureate David Baltimore focusing on microRNAs in cancer, and his residency at Stanford University, where he did postdoctoral work with National Academy of Medicine member Maximilian Diehn demonstrating that circulating tumor DNA serves as a powerful biomarker for molecular residual disease (MRD) after curative-intent localized lung cancer treatment. Dr. Chaudhuri has been awarded the Roentgen Research Award from the Radiological Society of North America, the Michael Fry Award by the Radiation Research Society, and is also a V Foundation V Scholar. Dr. Chaudhuri’s laboratory at Washington University focuses on the development and application of liquid biopsy cancer diagnostic technologies with the goal of more precisely personalizing solid tumor malignancy treatment. His laboratory is funded by the National Institutes of Health, the V Foundation, the Cancer Research Foundation, the Children’s Discovery Institute, the Children’s Tumor Foundation, the Alvin Siteman Cancer Research Fund, and the Melanoma Research Alliance.

Disclosures: